No Data
No Data
China Everbright Water to Pay Interest on Bonds on July 17
China Everbright Water (HKG:1857, SGX:U9E) will be paying interest on its 2023 second tranche medium-term bonds on July 17, a Wednesday filing with the Hong Kong Exchange said.The interest payable
China Everbright Water (01857): "23 Everbright Water MTN002" will pay interest on July 17.
China Everbright Water (01857) announced to ensure the smooth progress of China Everbright Water Co., Ltd.'s second medium-term notes (bond short name: 23 Everbright Water MTN002, bond code: 102381697) interest payment work in 2023, and facilitate investors to receive interest payment funds in a timely manner. The relevant matters are announced as follows: Issuance amount: RMB 1.5 billion yuan Issuance period: 3+2 years Bond interest rate during the interest period: 2.97% Interest payment date: July 17, 2024 (If it falls on a statutory holiday, it will be postponed to the next working day).
China Everbright Water (01857.HK) and Shanghai Jiaotong Construction have established a joint venture company.
China Everbright Water announced on June 18th that according to the terms of a franchise agreement signed on June 6, 2024, between the company, Shanghai Construction Group and Anyang Housing and Urban-Rural Development Bureau, the company and Shanghai Construction Group have established a joint venture company, Guangshui Water (Anyang) Co., Ltd. in China to undertake the operation of a sewage treatment plant in Anyang City, Henan Province with a registered capital of approximately 221 million yuan. The establishment of the new joint venture has resulted in the establishment of the new joint venture.
China Everbright Water Secures Water Treatment Project in Henan, China
China Everbright Water (SGX:U9E, HKG:1857) signed a concession agreement for Phase 1 of the Anyang Municipal Water Treatment Center for an investment amount of approximately 663.0 million yuan, a fili
Sinopec SSC (01033) signed a turnkey fixed-price contract with Saudi Aramco for the MGS Phase III Pipeline Project Groups 6 and 7 domestic procurement and construction, with a total investment of approximately RMB 7.956 billion.
Luye Pharma (02186) submitted a new drug application for Lisinopril Transdermal Patch (2 times/W) in Japan; Kingkey Fin Int (01468) signed a memorandum of understanding with PRIME on potential cooperation in developing and promoting solar power plants, energy and environmental technology solutions.
China Everbright Water (01857.HK) entered into a franchise agreement.
On June 6th, Gelunhui reported that China Everbright announced that on June 6, 2024, the company, Shanghai Construction and Anyang Housing Construction Bureau signed a franchise agreement for the project. According to this, a consortium will establish a project company. The total investment of the project is expected to be about 663 million yuan. The total investment amount shall not exceed 690 million yuan under any circumstances. The company will contribute about 219 million yuan to the project company as part of the registered capital of the project company. After the contribution is completed, the project company will be respectively owned by the company holding 99% equity and Shanghai Construction holding 1% equity.
No Data